ArticleFrontiers in endocrinology2026
Resting energy expenditure under fasting conditions is primarily explained by fat-free mass rather than cardiac autonomic markers.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Resting Energy Expenditure (REE) represents the largest component of total daily energy expenditure. While fat-free mass (FFM) is its primary predictor, substantial interindividual variability remains unexplained. The sympathetic nervous system has been implicated in the regulation of energy expenditure, but its contribution to REE under fasting conditions in humans is not yet determined. Methods: We investigated the relative contributions of body composition, circulating catecholamines, and cardiac autonomic modulation to REE in 38 healthy young participants following an overnight fast. REE was assessed by indirect calorimetry and FFM by bioelectrical impedance analysis. Cardiac autonomic activity was quantified through heart rate variability (HRV) analysis (time- and frequency-domain). Plasma epinephrine and norepinephrine were determined in a subsample ( Results: In a multivariable model including FFM, sex, and age, FFM was the dominant determinant of REE (R Conclusion: Under basal fasting conditions, REE is primarily associated with FFM, with an additional association with circulating epinephrine. Given the absence of associations with norepinephrine and HRV-derived parameters, the findings suggest a potential role of circulating catecholamines in interindividual variability in REE. However, direct conclusions regarding the physiological mechanisms involved cannot be drawn from the present observational study. HRV-derived cardiac autonomic markers were not associated with REE under standardized fasting conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.